Baird Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $639

Benzinga Newsdesk www.benzinga.com Negative 94.5%

Neg 94.5% Neu 0% Pos 0%

Baird analyst Catherine Schulte maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and lowers the price target from $653 to $639.